Cannabis and Female Fertility
How THC and CBD interact with ovulation, conception, and pregnancy outcomes.
This article is for information only and is not medical advice. Talk to a doctor before using cannabis for a health condition, and do not stop or change prescribed treatment on your own.
The endocannabinoid system genuinely does regulate ovulation and implantation—that's not marketing. But human fertility data is sparse and inconsistent. Heavy chronic use correlates with menstrual disruption and possibly slower conception; pregnancy exposure has weak evidence for adverse birth outcomes. Major obstetrics bodies recommend stopping before trying to conceive, mostly on precautionary grounds. Switching to 'fertility-friendly' strains or CBD alone? No evidence supports that.
Plain-language summary
The endocannabinoid system—a network of cell receptors throughout the body—is active in the ovaries, uterus, and developing embryo. Strong evidence[1][2] This means cannabis can interact with reproduction in principle. But whether heavy, chronic use meaningfully reduces real-world fertility is less clear. Human evidence is limited and mixed.
What the data actually shows:
- Chronic cannabis use is associated with menstrual cycle irregularities in some studies. Weak / limited[3]
- Regular use around conception may be linked to modestly lower odds of pregnancy per cycle in prospective cohort studies, though other studies find no effect and effect sizes are small. Disputed[4][5]
- In IVF cycles, regular cannabis use has been associated with fewer retrieved eggs in some reports. Weak / limited[6]
- Cannabis use during pregnancy is associated with increased miscarriage risk and lower birth weight, though these studies are confounded by tobacco, alcohol, and other lifestyle factors. Weak / limited[7][8]
This is not medical advice. If you are trying to conceive, are pregnant, or are undergoing fertility treatment, speak with a clinician about your individual situation.
What probably works (to protect fertility)
Stopping or significantly reducing cannabis use while actively trying to conceive. Weak / limited
The American College of Obstetricians and Gynecologists (ACOG) advises against cannabis use when planning pregnancy and during pregnancy. [9] This recommendation rests on mechanistic evidence and the precautionary principle rather than large randomized trials—which, for ethical reasons, do not exist for conception attempts.
The endocannabinoid system regulates the luteinizing hormone (LH) surge that triggers ovulation. Animal studies show that THC can blunt or delay this signal. Strong evidence[1] Anandamide, an endogenous cannabinoid, must rise and fall in a precise pattern for successful implantation. Strong evidence[2] Introducing exogenous THC adds variability to a process that depends on tight hormonal timing.
The mechanism is biologically plausible, but the clinical magnitude of effect in people is still not well quantified. Nevertheless, for people actively trying to conceive, cessation is the evidence-based recommendation.
No evidence supports 'fertility-friendly' strains, CBD-only switching, or specific consumption methods. The endocannabinoid receptors don't distinguish between THC sources.
What might work (but lacks evidence)
Switching to CBD-dominant products. No data
The logic is intuitive: if THC, not CBD, activates CB1 receptors that disrupt reproductive signaling, then CBD might be safer. But there are no human fertility studies on CBD specifically. Mechanistic plausibility is not evidence. Additionally, CBD products are frequently mislabeled and may contain more THC than labeled. [10]
Timing cannabis use away from the fertile window. No data
No studies have tested this. Anandamide signaling matters across the menstrual cycle, not just at ovulation, so the theoretical basis for avoiding only peak ovulation days is weak.
Tracking ovulation while gradually reducing use. Anecdote
Many people report more regular cycles after stopping heavy use. This is consistent with mechanism but has not been studied in controlled trials. It may help some individuals identify a personal threshold, but it is not a validated strategy.
What doesn't work or has weak evidence
'Cannabis reduces stress, which helps fertility.' No data
Stress reduction might have some value for overall health, but cannabis is not a validated fertility treatment. The endocannabinoid signaling disruption that may impair fertility happens whether or not you feel relaxed.
'Indica vs. sativa matters for reproductive hormones.' No data
The indica/sativa distinction is largely a marketing taxonomy with no validated relationship to cannabinoid potency or reproductive endocrinology. THC is THC regardless of plant heritage labels.
'Topicals and edibles bypass systemic effects because they don't enter the bloodstream.' Disputed
Edibles absolutely enter the bloodstream—that is how they produce effects. Most topicals do not generate significant systemic THC levels, but transdermal patches can. Do not assume a delivery method avoids systemic absorption without checking the specific product's pharmacokinetics.
'Microdosing avoids fertility effects.' No data
No dose-response data exist in humans for fertility outcomes. We do not know where a threshold lies, or if one exists.
What we don't know
Honestly, the gaps are larger than the evidence:
- The dose-response relationship between cannabis use frequency or quantity and time to pregnancy in humans.
- Whether occasional use (e.g., once weekly) has measurable fertility effects.
- Whether effects on fertility are fully reversible after cessation, and over what timeline.
- Whether CBD alone affects fertility in any direction.
- How cannabis interacts with conditions that affect fertility, such as PCOS or endometriosis.
- Whether male partner cannabis use combined with female use compounds or modifies risk (separate evidence exists on Cannabis and Male Fertility).
- Long-term effects on ovarian reserve with years of use.
The research base is constrained by ethical restrictions on experimenting in people attempting conception, by federal scheduling limits that historically blocked US research, and by the difficulty of isolating cannabis effects from confounders such as tobacco, alcohol, sleep, and socioeconomic factors.
Comparison with standard fertility approaches
Cannabis is not a fertility treatment and should not be evaluated as one. The relevant question is whether continuing cannabis use harms fertility relative to stopping or reducing it while pursuing standard care.
Standard preconception care includes folic acid supplementation, achieving a healthy body weight, screening for and treating thyroid or metabolic conditions, managing chronic illness, vaccination updates, and reducing or eliminating alcohol, tobacco, and recreational drugs. [9] Cannabis cessation fits into that last category in current clinical guidelines.
If you use cannabis medically—for chronic pain, nausea, PCOS-related hirsutism, endometriosis, or another indication—the decision is more complicated. Stopping a medication that works is not trivial. This conversation is best had with a clinician who understands your medical history, reproductive goals, and cannabis pharmacology. Some conditions for which cannabis is used have specific pregnancy-compatible alternatives worth discussing with a fertility specialist or obstetrician.
Risks
For people trying to conceive:
- Possible delay in time to pregnancy, though effect sizes in published studies are small and some studies find no association. Disputed[4][5]
- Possible reduction in the number of oocytes retrieved during IVF, reported in some cohort studies. Weak / limited[6]
If pregnancy occurs while using:
- Increased miscarriage risk in some observational studies, though confounding with smoking and alcohol use is substantial. Weak / limited[7]
- THC crosses the placenta. Prenatal exposure is associated in meta-analysis with lower birth weight and with possible neurodevelopmental effects in offspring; the clinical significance and magnitude of these effects are debated among researchers. Weak / limited[8]
- THC and its metabolites are present in breast milk and can persist for weeks. Strong evidence[12]
General:
- Cannabis hyperemesis syndrome (chronic, cyclic vomiting) can mimic or worsen morning sickness during pregnancy.
- Drug testing during prenatal care can have legal and custody consequences in some US jurisdictions regardless of local legality—a non-medical but serious risk.
This is not medical advice. Your age, cycle regularity, medical history, partner factors, and reasons for using cannabis matter more than any general summary. Talk to a clinician you trust.
Sources
- Peer-reviewed Walker OS, Holloway AC, Raha S. The role of the endocannabinoid system in female reproductive tissues. Journal of Ovarian Research, 2019; 12(1):3.
- Peer-reviewed Maccarrone M. Endocannabinoid signaling at the periphery: 50 years after THC. Trends in Pharmacological Sciences, 2015; 36(5):277-296.
- Peer-reviewed Jukic AM, Weinberg CR, Baird DD, Wilcox AJ. Lifestyle and reproductive factors associated with follicular phase length. Journal of Women's Health, 2007; 16(9):1340-1347.
- Peer-reviewed Wise LA, Wesselink AK, Hatch EE, et al. Marijuana use and fecundability in a North American preconception cohort study. Journal of Epidemiology and Community Health, 2018; 72(3):208-215.
- Peer-reviewed Mumford SL, Flannagan KS, Radoc JG, et al. Cannabis use while trying to conceive: a prospective cohort study evaluating associations with fecundability, live birth and pregnancy loss. Human Reproduction, 2021; 36(5):1405-1415.
- Peer-reviewed Klonoff-Cohen HS, Natarajan L, Chen RV. A prospective study of the effects of female and male marijuana use on in vitro fertilization (IVF) and gamete intrafallopian transfer (GIFT) outcomes. American Journal of Obstetrics and Gynecology, 2006; 194(2):369-376.
- Peer-reviewed Metz TD, Borgelt LM. Marijuana use in pregnancy and while breastfeeding. Obstetrics and Gynecology, 2018; 132(5):1198-1210.
- Peer-reviewed Gunn JK, Rosales CB, Center KE, et al. Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis. BMJ Open, 2016; 6(4):e009986.
- Government American College of Obstetricians and Gynecologists. Committee Opinion No. 722: Marijuana Use During Pregnancy and Lactation. Obstetrics and Gynecology, 2017; 130:e205-209. Reaffirmed 2021.
- Peer-reviewed Bonn-Miller MO, Loflin MJE, Thomas BF, Marcu JP, Hyke T, Vandrey R. Labeling accuracy of cannabidiol extracts sold online. JAMA, 2017; 318(17):1708-1709.
- Government National Academies of Sciences, Engineering, and Medicine. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington, DC: The National Academies Press, 2017.
- Reported Martin N. Take a Valium, Lose Your Kid, Go to Jail. ProPublica, 2015.
How this page was made
Generation history
Drafted with AI assistance and checked by a separate automated fact-check pass. Not every article has been read by a person. See how articles are made.
Related
- Cannabis and Male Fertility — Regular cannabis use may lower sperm count; stopping is low-risk and evidence-supported.
- Cannabis and Polypharmacy Risks — How cannabis affects multiple-medication regimens, and which interactions are real.
- Does Cannabis Cause Permanent Infertility? — The claim overstates the evidence. Heavy use affects sperm parameters; permanent sterility...
- Epidiolex (Cannabidiol) — FDA-approved cannabidiol for rare seizure syndromes: what the trials show, what they don't...